Document Detail


Eclampsia : before and after magnesium sulphate.
MedLine Citation:
PMID:  16751814     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This study was done to see the incidence and impact of changes in the intervention strategy for the management of eclampsia in a maternity hospital on maternal and perinatal outcome. Analysis of case records of all eclampsia cases over two different study periods designated as study period A (April, 1994 to Oct, 1996) and study period B (April, 2000 to April, 2001) were done. Total number of eclampsia cases who received intervention over two different study period (46 in study period A and 47 in study period B) were comparable despite the difference in the duration of study period. During study period A, diazepam was used as anticonvulsant, whereas magnesium sulphate was used to control fits during study period B. Incidence of eclampsia has markedly increased in this hospital (0.12% vs 0.29%). Epidemiology and clinical profile of eclamptic patients do not show remarkable change. There was no maternal death in study period B (April, 2000 to April, 2001) whereas there was one maternal death in the study period A (April, 1994 to October, 1996). Marked improvement was noticed in terms of recurrence of fit (19.13% vs 73.91%) with change in the intervention strategy. Perinatal deaths were fewer in study period B (20% vs 33%). Overall, it seems that care of eclamptic patients and use of magnesium sulphate as anticonvulsant has resulted in positive impact on maternal outcome.
Authors:
P Chaudhary
Related Documents :
15894884 - Preventing pregnancy-induced hypertension: are there regional differences for this glob...
12598964 - Endotoxemia associated with intussusception and its diagnostic and surgical interventions.
19177044 - Repeated dosing of digoxin-fragmented antibody in preterm eclampsia.
8914554 - Improved perinatal mortality rates in 1001 patients with severe pre-eclampsia.
19092984 - Endometrial and myometrial secretion of androgens and estrone during early pregnancy an...
15166754 - Induction of testosterone metabolism by esomeprazole in a cyp2c19*2 heterozygote.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  JNMA; journal of the Nepal Medical Association     Volume:  44     ISSN:  0028-2715     ISO Abbreviation:  JNMA J Nepal Med Assoc     Publication Date:    2005 Oct-Dec
Date Detail:
Created Date:  2006-06-05     Completed Date:  2008-05-20     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0045233     Medline TA:  JNMA J Nepal Med Assoc     Country:  Nepal    
Other Details:
Languages:  eng     Pagination:  124-8     Citation Subset:  IM    
Affiliation:
Maternity Hospital, Thapathali, Kathmandu, Nepal.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Anticonvulsants / therapeutic use*
Diazepam / therapeutic use*
Drug Therapy, Combination
Eclampsia / drug therapy*
Female
Hospitals, Maternity / statistics & numerical data
Humans
Magnesium Sulfate / therapeutic use*
Nepal / epidemiology
Nifedipine / therapeutic use
Pregnancy
Premature Birth / epidemiology
Retrospective Studies
Stillbirth / epidemiology
Tocolytic Agents / therapeutic use
Treatment Outcome
Chemical
Reg. No./Substance:
0/Anticonvulsants; 0/Tocolytic Agents; 21829-25-4/Nifedipine; 439-14-5/Diazepam; 7487-88-9/Magnesium Sulfate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Trend of blood group distribution among the Jirels of Nepal.
Next Document:  Medication counseling center in a teaching hospital.